慢性閉塞性肺疾患の診断と外来治療: レビュー
Craig M Riley1, Frank C Sciurba1
1Division of Pulmonary, Department of Medicine, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
JAMA
|February 27, 2019
まとめ
慢性閉塞性肺疾患 (COPD) の治療は進化しています 主要な治療法は,長時間作用する支氣管拡張剤,吸入用コルチコステロイド,肺リハビリテーション,低酸素症に対する酸素療法で,患者のアウトカムを改善します.
科学分野:
- 肺医学
- 内科 医学
背景:
- 慢性閉塞性肺疾患 (COPD) は アメリカで3千万人の成人に 影響し,主要な死因であり,医師の診察を多く行う原因となっています.
- 主要医療従事者はCOPDの診断と管理に困難に直面し,その臨床的特徴と治療への反応が変化するからです.
- 慢性肺炎の診断と治療の急速な進歩により 最適な患者ケアのための最新の知識が必要になります
研究 の 目的:
- COPDの診断と管理における現在の理解と最近の進歩をレビューする.
- 患者の治療結果を改善するために 根拠に基づいた治療戦略の重要性を強調する.
主な方法:
- 診断はスピロメトリーによるもので,不完全で逆戻り可能な排気流の制限を評価する.
- 治療は,疾患の重症度,症状 (呼吸不全,咳,唾液),および悪化の頻度によって導かれます.
- 重要な介入には 禁煙,ワクチン接種,長時間作用する支氣管拡張剤,吸入用コルチコステロイド,肺リハビリテーション,補充酸素が含まれます.
主要な成果:
- 長期にわたって作用する支柱管拡張剤,吸入用コルチコステロイド,肺リハビリテーションは症状を効果的に軽減し,機能を改善し,悪化を軽減します.
- 休息時の低酸素症 (Spo2 < 89%) の補充酸素は生存率を向上させることが証明されています.
- 肺のリハビリテーションは 十分に活用されていないが 症状と運動耐性を高めます
結論:
- COPDは複雑で,集中的で個別的な治療が必要です.
- 呼吸器拡張剤,吸入用コルチコステロイド,肺リハビリテーション,酸素療法による適切な使用は,生活の質と生存率を大幅に改善します.
- 先進的な治療法は特定の患者プロファイルで利用可能であり,継続的な臨床更新の必要性を強調しています.
関連する概念動画
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K
COPD: Management Using Bronchodilators and Corticosteroids
705
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
705
Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.0K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.0K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K


